A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients-Reference-Cited by-同舟云学术

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

Published:2018-06-20 Issue:4 Volume:245 Page:421-432
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Martínez-Terroba Elena¹²,Behrens Carmen³,de Miguel Fernando J¹⁴,Agorreta Jackeline¹²⁵⁶,Monsó Eduard⁷⁸,Millares Laura⁷⁸,Sainz Cristina¹⁶,Mesa-Guzman Miguel⁵⁹,Pérez-Gracia José Luis⁵⁶¹⁰,Lozano María Dolores⁵⁶¹¹,Zulueta Javier J⁵⁶¹²,Pio Ruben¹⁴⁵⁶,Wistuba Ignacio I³¹³,Montuenga Luis M¹²⁵⁶,Pajares María J¹²⁵⁶^ORCID

Affiliation:

1. Program in Solid Tumours, CIMA; Pamplona Spain

2. Department of Histology and Pathology, School of Medicine; University of Navarra; Pamplona Spain

3. Department of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

4. Department of Biochemistry and Genetics, School of Sciences; University of Navarra; Pamplona Spain

5. Navarra Health Research Institute (IDISNA); Pamplona Spain

6. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC); Madrid Spain

7. Respiratory Diseases Department; Parc Taulí University Hospital; Sabadell, Barcelona Spain

8. Ciber de Enfermedades Respiratorias - CIBERES, Instituto de Salud Carlos III; Madrid Spain

9. Department of Thoracic Surgery; Clínica Universidad de Navarra; Pamplona Spain

10. Department of Oncology; Clínica Universidad de Navarra; Pamplona Spain

11. Department of Pathology; Clínica Universidad de Navarra; Pamplona Spain

12. Department of Neumology; Clínica Universidad de Navarra; Pamplona Spain

13. Department of Translational Molecular Pathology; The University of Texas, MD Anderson Cancer Center; Houston TX USA

Funder

AECC Scientific Foundation

Ciber de Enfermedades Respiratorias-CIBERES-FEDER

CIBERONC

FIMA

Sociedad Española de Neumología y Cirugía Torácica

Spanish Ministry of Economy and Innovation and Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference50 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Recurrence after surgery in patients with NSCLC;Uramoto;Transl Lung Cancer Res,2014

3. Postoperative adjuvant systemic therapy in completely resected non-small-cell lung cancer: a systematic review;Bradbury;Clin Lung Cancer,2017

4. Low-dose computed tomography for lung cancer screening: clinical and coding considerations;Shieh;Chest,2017

5. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nomogram based on radiomics for predicting the high-grade histologic patterns in pure-solid clinical stage IA lung adenocarcinoma;2023-09-13

2. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma;Channels;2023-05-03

3. OverexpressedMalat1Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma Microenvironment;2023-03-23

4. Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma;BMC Medical Genomics;2022-12-11

5. Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma;Frontiers in Oncology;2022-11-01